m.eriksen

TL2 Moderator · Lublin

Contributes reviews on supplier material. Based in Lublin.

Joined 23 July 2025 · last posted 2d

64 posts, newest first. Showing up to 150.

Publication patterns in the BPC-157 literature, examined Replied, post #45 · Compounds › Repair & healing peptides · 26 Jul 2026 · 3 likes The absence of adequately powered published randomised human trials is the central fact about BPC-157. This site states that plainly rather than hedging. Mechanistic…
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #97 · Practice › Dosing & titration · 25 Jul 2026 · 0 likes On post #93 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #10 · Clinical › Bloodwork · 17 Jul 2026 · 4 likes Picking up post #7: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
Common supplements people ask about, assessed one at a time Replied, post #58 · Practice › Interactions · 17 Jul 2026 · 1 like Worth separating two things that post #54 runs together. Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class…
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #35 · Compounds › Repair & healing peptides · 16 Jul 2026 · 0 likes The absence of adequately powered published randomised human trials is the central fact about BPC-157. This site states that plainly rather than hedging. Mechanistic…
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #84 · Analytics › Home & field testing · 14 Jul 2026 · 9 likes What physical quantity does the device measure? A colorimetric or lateral-flow method typically responds to a class of chemistry rather than to a specific molecule. It…
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #67 · Analytics › Home & field testing · 9 Jul 2026 · 1 like I read post #65 twice before replying, because I had assumed the opposite. Molecular tests: DNA or RNA tests are not applicable to peptides, which do not contain…
Mass error in ppm: the arithmetic and the caveat — a second dataset Replied, post #17 · Analytics › Mass spectrometry · 7 Jul 2026 · 8 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
A structured critique template this community uses — a second dataset Replied, post #28 · Evidence › Study critique · 4 Jul 2026 · 0 likes I read post #26 twice before replying, because I had assumed the opposite. Bias towards the null and bias away from the null: different criticisms have different…
Request: tag synonyms surfaced in search Replied, post #8 · Meta › Feature requests · 29 Jun 2026 · 0 likes Community support: if other people support your request, they can reply with "+1" or "I would use that too". Widely-requested features are prioritised.
Alcohol: what is documented and what is folklore Replied, post #82 · Practice › Interactions · 28 Jun 2026 · 11 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.
Pooling trials with different estimands Replied, post #5 · Evidence › Meta-analyses · 3 Jun 2026 · 25 likes Picking up post #2: that is the part I would want checked first. Pooled estimates and heterogeneity: when trials differ in population, duration, or comparator, a pooled…
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #4 · Practice › Storage & stability · 31 May 2026 · 5 likes Vial integrity: once a vial is entered with a needle repeatedly, the rubber closure degrades and the integrity fails. Using the same vial repeatedly over weeks or…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #30 · Practice › Reconstitution · 30 Apr 2026 · 0 likes post #29 is right about the mechanism and I think understates the practical bit. A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL…
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #116 · Pharmacology › Pharmacokinetics · 23 Apr 2026 · 33 likes Coming back to post #114, because the follow-up matters more than the original answer. Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days.…
Prescription portability between countries Replied, post #8 · Access › International · 14 Apr 2026 · 2 likes Insurance and coverage: coverage decisions are national. A compound approved in one country might not be covered by insurance in another. Checking both approval and…
Follow-up: Sleep quality changes during weight loss Replied, post #4 · Wellbeing › Sleep · 13 Apr 2026 · 2 likes On post #2 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you…
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #25 · Practice › Administration · 9 Apr 2026 · 9 likes Picking up post #22: that is the part I would want checked first. Leak-back after withdrawal: a small amount of liquid on the skin after withdrawal is ordinary. Whether…
Revisiting: Drawing up with one needle and injecting with another Replied, post #80 · Practice › Administration · 8 Apr 2026 · 17 likes Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It is not always necessary and shallower angles can work, but 90 degrees into a small…
Spike-and-recover accuracy for a peptide assay Replied, post #22 · Analytics › Method validation · 7 Apr 2026 · 0 likes Coming back to post #20, because the follow-up matters more than the original answer. Limits of detection and quantitation: LOD is the lowest concentration that…
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #49 · Practice › Reconstitution · 20 Mar 2026 · 8 likes I read post #47 twice before replying, because I had assumed the opposite. How much of the diluent volume the powder itself displaces: for a small peptide vial, the…
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #52 · Outcomes › Progress reports · 14 Feb 2026 · 8 likes post #51 is right about the mechanism and I think understates the practical bit. Non-scale victories: muscle gain or maintenance, clothing fit, energy level, and…
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #87 · Wellbeing › Mental health · 6 Feb 2026 · 2 likes Substance use: if someone has a history of substance use, appetite suppression and weight loss can shift thinking about body and substance use. This is a risk factor…
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #37 · Sourcing › Red flags · 4 Jan 2026 · 26 likes Inability to trace lots: if you ask "where was this synthesised, by whom, under what conditions" and cannot get a clear answer, that is a red flag. Traceability is not…
Oral semaglutide bioavailability and its variability between people Replied, post #21 · Compounds › Oral incretins · 15 Dec 2025 · 12 likes Oral bioavailability is variable between people. Some people absorb well; others absorb poorly. That inter-individual variation is larger than with injectables and is…
Robustness: the parameters worth deliberately varying Replied, post #39 · Analytics › Method validation · 3 Dec 2025 · 6 likes Linearity: the detector response is proportional to compound concentration across the working range. Demonstrated by running standards at multiple concentrations and…
Coming back to: Feature request: should a dose-equivalence tool exist at all? Replied, post #23 · Data & Tools › Calculators · 30 Nov 2025 · 26 likes Storage lookup: which conditions (temperature, time) are you considering storing in, and how much stability loss is expected? The calculator gives a rough estimate…
Coming back to: Injection-site reactions: describing them precisely enough to be useful Replied, post #9 · Practice › Side effects · 22 Nov 2025 · 3 likes Fatigue: commonly reported, frequently multifactorial. It is worth asking whether other factors have changed (sleep, training volume, diet adequacy, hydration) before…
Thyroid function tests during substantial weight change Replied, post #123 · Clinical › Bloodwork · 5 Nov 2025 · 1 like Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading them together is more informative than reading one value in isolation. An elevated…
How to read a phase 2 result without treating it as a phase 3 result — what changed since Replied, post #12 · Compounds › Retatrutide · 27 Oct 2025 · 20 likes Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison of tirzepatide (dual) to retatrutide (triple) would answer that question. The…
Publishing an inconvenient result: a case study — the long version Replied, post #6 · Sourcing › Independent verification · 9 Oct 2025 · 0 likes post #5 is right about the mechanism and I think understates the practical bit. Blind sampling: submitting without the laboratory or seller knowing the source removes…
What a purity-only report leaves out Replied, post #24 · Sourcing › Independent verification · 24 Sep 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Aggregated purity results across four services, with caveats — a second dataset Replied, post #55 · Data & Tools › Datasets · 8 Sep 2025 · 25 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Confounding by indication, explained with a concrete example Replied, post #7 · Evidence › Study critique · 31 Aug 2025 · 3 likes Building consensus on which criticisms matter: if everyone agrees that the sample size is small but only you think that affects the conclusion, maybe your criticism is…
Revisiting: List price versus negotiated price versus what you pay Replied, post #29 · Access › Pricing · 11 Aug 2025 · 12 likes Subscription services and subscriptions: some online clinics bundle compounds into subscription models with different pricing. Understanding the terms before committing…
Coming back to: What published stability data actually covers, and what it does not Replied, post #88 · Practice › Storage & stability · 16 Jul 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #21 · Evidence › Journal club · 31 May 2025 · 2 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
[2026 update] Clearance pathways and what renal impairment changes Replied, post #13 · Pharmacology › Pharmacokinetics · 24 May 2025 · 5 likes Bioavailability: oral semaglutide has low bioavailability (roughly 1%) due to peptide instability. That is why the oral dose (14 mg) is so much larger than the…
Follow-up: Documentation that appears only after payment Replied, post #71 · Sourcing › Red flags · 12 May 2025 · 3 likes Documentation quality as a signal: a supplier that reports method identifiers, distinguishes specification from result, and states the counter-ion form is telling you…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #77 · Compounds › Tirzepatide · 5 May 2025 · 4 likes Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that means steady state is reached slightly faster and the post-dose…
Reporting a disappointing outcome, and why it belongs here Replied, post #10 · Outcomes › Progress reports · 15 Apr 2025 · 10 likes Rate of change: reporting progress as "lost 5 kg in 12 weeks" is more useful than "currently at 82 kg" because the rate tells you whether the change is steady,…
Follow-up: What other technical communities get right that we do not Replied, post #51 · Lounge › Off topic · 28 Mar 2025 · 29 likes post #50 is right about the mechanism and I think understates the practical bit. Not a rules-free zone: the guidelines still apply. No phones, no Telegram, no…
Why one laboratory's 98.4% and another's 96.1% may not contradict Replied, post #2 · Analytics › Method validation · 27 Mar 2025 · 0 likes Stability-indicating method: one that can separate a compound from its degradation products. Critical for assay methods that claim to measure actual degradation (as…
Why cagrilintide alone is discussed so much less than in combination Started this topic · Compounds › Cagrilintide & amylin analogues · 20 Mar 2025 · 18 likes Why cagrilintide alone is discussed so much less than in combination I have a specific reason for asking rather than idle curiosity, and the context is below. Session…
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #105 · Access › International · 17 Mar 2025 · 20 likes On post #101 — agreed on the reasoning, with one qualification. Country-by-country legality: compound approval and legal status differ substantially by jurisdiction.…
Maintainer handover: how it works Replied, post #37 · Meta › Wiki maintenance · 15 Mar 2025 · 3 likes Worth separating two things that post #33 runs together. Redundancy: if two maintained pages cover largely the same ground, consolidation might improve clarity.…
Validating a method you did not develop — does this still hold? Replied, post #44 · Analytics › Method validation · 25 Feb 2025 · 0 likes Why two laboratories may disagree: after validating the same method, they may still report different purity on the same sample due to integration differences, column…
Talking to a therapist about this specifically — does this still hold? Replied, post #15 · Wellbeing › Mental health · 9 Feb 2025 · 0 likes Picking up post #12: that is the part I would want checked first. Body image and weight loss: large weight loss changes a person's relationship with their body in ways…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #21 · Practice › Reconstitution · 27 Jan 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
The topic list is dense — is that deliberate? Replied, post #82 · Meta › Site feedback · 13 Jan 2025 · 21 likes Navigation problems: if you cannot find something you expected to exist, or the path to it is unclear, report it. Site architecture affects usability.
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #49 · Compounds › Semaglutide · 28 Dec 2024 · 8 likes Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management indication is approved in many European jurisdictions but not all, and…
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #72 · Evidence › Journal club · 26 Dec 2024 · 32 likes I read post #70 twice before replying, because I had assumed the opposite. SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The…
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #38 · Compounds › Cagrilintide & amylin analogues · 20 Dec 2024 · 9 likes Reading the phase 2 paper: it establishes tolerability and efficacy in a selected population on a defined dose escalation. It does not establish the lowest effective…
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #7 · Compounds › Semaglutide · 18 Dec 2024 · 0 likes Picking up post #4: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #91 · Compounds › Tirzepatide · 16 Dec 2024 · 15 likes SURMOUNT-OSA is notable because it used an objective physiological endpoint, the apnoea-hypopnoea index, rather than a symptom scale. Two parallel trials, with and…
Gallbladder disease risk with rapid weight loss Replied, post #39 · Clinical › Comorbidities · 4 Dec 2024 · 22 likes On post #35 — agreed on the reasoning, with one qualification. Chronic kidney disease: compounds in this class have renal benefit in people with kidney disease. The…
Time to steady state after a dose increase Replied, post #13 · Pharmacology › Pharmacokinetics · 2 Nov 2024 · 0 likes I read post #11 twice before replying, because I had assumed the opposite. Fasting requirement for oral semaglutide: food and large fluid volumes reduce absorption. The…
[2026 update] Step therapy requirements and how to satisfy them Replied, post #7 · Access › Insurance & coverage · 28 Oct 2024 · 0 likes Coming back to post #5, because the follow-up matters more than the original answer. Coverage for weight management versus diabetes: many formularies cover these…
When a red flag was a misunderstanding, and the retraction Replied, post #33 · Sourcing › Red flags · 13 Oct 2024 · 25 likes Coming back to post #31, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
Circumference measurements as a poor man's composition estimate Replied, post #35 · Outcomes › Body composition · 2 Aug 2024 · 16 likes Maintenance phase: tracking body composition during maintenance (weight stable) is different from tracking during active loss. Changes are smaller and precision becomes…
Guidelines revision: what changed and why Replied, post #88 · Meta › Announcements · 27 Jul 2024 · 1 like post #87 answers the question as asked. The question underneath it is different. Feedback to announcements: if you have feedback on an announced change (not a question,…
Guidelines revision: what changed and why Replied, post #63 · Meta › Announcements · 26 Jul 2024 · 0 likes Staff-only posts: some announcements are visible only to staff (concerning internal operations). Members see public announcements.
How to ask for a dose change without antagonising anyone Replied, post #4 · Clinical › Prescriber conversations · 9 Jul 2024 · 16 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Units, standards, and other things that quietly hold the world together — one year on Started this topic · Lounge › Off topic · 27 Jun 2024 · 50 likes On the subject in the title: Units, standards, and other things that quietly hold the world together — one year on Working notes rather than a conclusion. Lower-stakes…